Sveinung Hole
Director/Board Member at BERGENBIO ASA
Network origin in Sveinung Hole first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 39 | |
Sarsia Seed Management AS
 Sarsia Seed Management AS Investment ManagersFinance Sarsia Seed Management AS is a venture capital firm headquartered in Bergen, Norway. The company was founded in 2006.
3
| Private Company | Investment Managers | 3 |
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Tromsø Forskningsstiftelse
1
| Private Company | 1 | |
Plasmacute AS
 Plasmacute AS Medical SpecialtiesHealth Technology Part of Novel Diagnostics AS, Plasmacute AS is a Norwegian company that develops diagnostic sample products. The company is based in Bergen, Norway.
1
| Subsidiary | Medical Specialties | 1 |
Nordic & Europe Health Invest AS
 Nordic & Europe Health Invest AS Investment ManagersFinance Nordic & Europe Health Invest AS target companies primarily from the Nordic Region, but will consider investments in other Northern Europe countries. It will invest between NOK 100 million and NOK 150 million in each company and will make follow-up investments. It seeks a controlling and non-majority stake position in firms with the health care sector such as pharmaceutical/nutraceuticals, diagnostics, novel products for lowering of health care spending, medical devices and healthcare providers. Occasionally it will invest up to 20 % in early stage companies.
1
| Private Eq Fd/Alt Invt | Investment Managers | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sveinung Hole via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Bergen | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
| University of Oslo | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree | |
Pluvia AS
 Pluvia AS Miscellaneous Commercial ServicesCommercial Services Pluvia AS operates as a research-based pharmaceutical company. The company is headquartered in Bergen, Norway. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
Novel Diagnostics AS
 Novel Diagnostics AS BiotechnologyHealth Technology Novel Diagnostics AS provides biomedical research and diagnostics development services. It sells and develops medical and diagnostic products and drives commercialization of research results. The firm also invests in securities; either in form of follow-up investments in companies already has invested in, or as part of other strategic investments. The company was founded on June 10, 2002 and is headquartered in Bergen, Norway. | Biotechnology | Chief Executive Officer Chief Executive Officer Director/Board Member | |
ScreenCancer AS
 ScreenCancer AS Medical/Nursing ServicesHealth Services ScreenCancer AS offers cancer screening and diagnostic program to the public. It provides a panel of screening tests for several major cancers such as colorectal, bladder, breast, prostate, skin, and lung. The company was founded by Christian Horn and Dagfinn Steinar Ogreid in 2007 and is headquartered in Sola, Norway. | Medical/Nursing Services | Director of Finance/CFO Founder Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| King's College London | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Piramed Ltd.
 Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| Norwegian School of Economics & Business Administration | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
| University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree | |
| ULTIMOVACS ASA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Papyrus Therapeutics, Inc.
 Papyrus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Papyrus Therapeutics, Inc. is a preclinical stage biopharma American company that focuses on developing cancer therapeutics based on a novel target, opioid-binding cell adhesion molecule (OPCML). Papyrus Therapeutics is based in Oxford, UK. The company's expertise in this target is based on years of research and multiple publications by the company's co-founder and chief scientific adviser, Professor Hani Gabra. The company was founded by Paul Blake and Hani Gabra, and Paul Blake has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| LYTIX BIOPHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sarsia Innovation AS
 Sarsia Innovation AS Investment ManagersFinance Sarsia Innovation AS invests in companies located in the northern part of Norway. Selected companies are from various sectors but they all are developing new concepts in their field. The fund is currently closed for new investments. | Investment Managers | Director/Board Member Corporate Officer/Principal | |
Piper Sandler Ltd.
 Piper Sandler Ltd. Investment Banks/BrokersFinance Part of Piper Sandler Cos., Piper Sandler Ltd. is a brokerage services provider. The company is based in London, UK. The British company was founded in 1999. Neil Robert Mackison has been the CEO of the company since 2006. | Investment Banks/Brokers | Chief Executive Officer Analyst-Equity | |
| NORDA ASA | Miscellaneous Commercial Services | Director of Finance/CFO President | |
APIM Therapeutics AS
 APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Ernst & Young AS
 Ernst & Young AS Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young AS is a Norwegian company that provides accounting services. The company is based in Oslo, Norway. The CEO of the company is Christin Erichsen Bøsterud. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| Oxford Brookes University | College/University | Masters Business Admin Graduate Degree | |
Sarsia Venture Management AS
 Sarsia Venture Management AS Investment ManagersFinance Sarsia Venture Management AS (SVM) is a venture capital advisory and management firm based in Bergen, Norway. They manage and advise the Sarsia Life Science Fund, established in 2005, which focuses on life science and biotechnology opportunities in the Nordic region. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
| WEIFA ASA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| THERACRYF PLC | Medical/Nursing Services | Chairman Director/Board Member | |
Balter Medical AS
 Balter Medical AS Medical SpecialtiesHealth Technology Balter Medical AS engages in the development and commercialization of biomedical technology. Its product assists healthcare professionals in diagnosing patients with Melanoma. The company was founded by Jakob Johan Stamnes and Knut Stamnes on December 13, 2000 and is headquartered in Bergen, Norway. | Medical Specialties | Director/Board Member Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
Investinor AS
 Investinor AS Investment ManagersFinance Investinor AS is a Venture Capital firm, a subsidiary of Innovasjon Norge founded in 2008. The company is headquartered in Trondheim. | Investment Managers | Chairman Private Equity Investor | |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chief Operating Officer | |
Royal Pharmaceutical Society of Great Britain
 Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Chief Executive Officer | |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Undergraduate Degree | |
| Norwegian University of Science & Technology | College/University | Graduate Degree | |
| ARCTICZYMES TECHNOLOGIES ASA | Medical Specialties | Director/Board Member | |
Meteva AS
 Meteva AS Financial ConglomeratesFinance Meteva AS engages in investing activities. Its investment activities include participating as owners, lenders and guarantors in other companies. The company may also conduct regular trading. The company was founded on October 14, 2005 and is headquartered in Blomsterdalen, Norway. | Financial Conglomerates | Director/Board Member | |
| Bergens Forskningsstiftelse | Chief Executive Officer | ||
| Stiftelsen Kristian Gerhard Jebsen | Chief Executive Officer | ||
| London Business School | College/University | Masters Business Admin | |
Uni Targeting Research AS
 Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Biotechnology | Chairman | |
| RECKITT BENCKISER GROUP PLC | Household/Personal Care | Sales & Marketing | |
Marineholmen Forskningspark AS
 Marineholmen Forskningspark AS Real Estate DevelopmentFinance Marineholmen Forksningspark AS operates, manages, and leases real properties. The company was founded on November 18, 1985 and is headquartered in Bergen, Norway. | Real Estate Development | Director/Board Member | |
Catalent Pharma Solutions Ltd.
 Catalent Pharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions Ltd. develops and markets drug delivery systems. The company is headquartered in Swindon, GB. | Pharmaceuticals: Major | Corporate Officer/Principal | |
DCC Healthcare Ltd.
 DCC Healthcare Ltd. Medical DistributorsDistribution Services DCC Healthcare Ltd. supplies medical, surgical, and laboratory equipment and pharmaceuticals to the Irish healthcare sector. The company is headquartered in Stillorgan, Ireland. | Medical Distributors | Chief Executive Officer | |
Sarsia Development AS
 Sarsia Development AS Investment ManagersFinance Sarsia Development AS invests in early and later-stage companies located in the northern part of Norway. It targets life sciences and biotechnology companies. It seeks minority stake positions in selected companies. | Investment Managers | Director/Board Member | |
Eli Lilly Norge AS
 Eli Lilly Norge AS Medical DistributorsDistribution Services Eli Lilly Norge AS engages in the provision of pharmaceutical products and services. Its commodities were developed for the treatment of diabetes, cardiovascular diseases, cancer, nervous system, osteoporosis, psoriasis, rheumatology, urology, and growth failure. The company was founded in 1976 and is headquartered in Oslo, Norway. | Medical Distributors | Corporate Officer/Principal | |
Aenova Holding GmbH
 Aenova Holding GmbH Medical DistributorsDistribution Services Aenova Holding GmbH provides supplies to the pharmaceutical and healthcare industries. The firm develops, produces, and markets solid dosage products such as soft and hard capsules, tablets, film-coated tablets, and effervescent tablets. Its services include production, supply chain management, packaging, support and analytics. The company was founded in 2008 and is headquartered in Starnberg, Germany. | Medical Distributors | Chief Executive Officer | |
| Transparency International Norway | Director/Board Member |
Statistics
International
| Norway | 31 |
| United Kingdom | 16 |
| United States | 2 |
| Denmark | 2 |
| Sweden | 2 |
Sectoral
| Health Technology | 16 |
| Consumer Services | 11 |
| Commercial Services | 8 |
| Finance | 8 |
| Distribution Services | 4 |
Operational
| Director/Board Member | 167 |
| Corporate Officer/Principal | 90 |
| Chairman | 53 |
| Independent Dir/Board Member | 34 |
| Chief Tech/Sci/R&D Officer | 31 |
Most connected contacts
| Insiders | |
|---|---|
| Susan Foden | 32 |
| François Thomas | 25 |
| Martin Olin | 25 |
| Hilde Furberg | 21 |
| Erlend Petter Skagseth | 17 |
| Jon-Øyvind Eriksen | 16 |
| Karl-Johan Jakola | 15 |
| Richard Stuart Godfrey | 15 |
| Stein Holst Annexstad | 15 |
| David Wilson | 14 |
| Kari Grønås | 12 |
| Kristin Louise A. Wilhelmsen | 12 |
| Gayle Mills | 12 |
| Anders Lennart Tullgren | 12 |
| Øivind Enger | 12 |
- Stock Market
- Insiders
- Sveinung Hole
- Company connections
